https://orcid.org/0000-0001-5706-2411
Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Vidhu Agarwal, Tara Chand Yadav, Akhilesh Tiwari & Pritish Kumar Varadwaj. (2023) Insights into structure and activity relationship of clinically mutated PER1 and PER2 class A β-lactamase enzymes. Journal of Biomolecular Structure and Dynamics 41:10, pages 4295-4312.
Read now
Read now
M. Shivapriya Pingali, Anirudh Singh, Vishal Singh, Amaresh Kumar Sahoo, Pritish Kumar Varadwaj & Sintu Kumar Samanta. (2023) Docking and molecular dynamics simulation for therapeutic repurposing in small cell lung cancer (SCLC) patients infected with COVID-19. Journal of Biomolecular Structure and Dynamics 41:1, pages 16-25.
Read now
Read now
Shashank M. Patil, Reshma Mary Martiz, Ramith Ramu, Prithvi S. Shirahatti, Ashwini Prakash, Jagadeep Chandra S & V. Lakshmi Ranganatha. (2022) In silico identification of novel benzophenone–coumarin derivatives as SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) inhibitors. Journal of Biomolecular Structure and Dynamics 40:23, pages 13032-13048.
Read now
Read now
Hani S. H. Mohammed Ali, Hisham N. Altayb, Ahmad Firoz, Ahmed Atef Mohamed Bayoumi, Abdelfatteh El Omri & Kamel Chaieb. (2022) Inhibitory activity of marine sponge metabolites on SARS-CoV-2 RNA dependent polymerase: virtual screening and molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics 40:20, pages 10191-10202.
Read now
Read now
William HK Schilling & Nicholas J White. (2021) Does hydroxychloroquine still have any role in the COVID-19 pandemic?. Expert Opinion on Pharmacotherapy 22:10, pages 1257-1266.
Read now
Read now
Articles from other publishers (15)
Mohnad Abdalla & Amgad M. Rabie. (2023) Dual computational and biological assessment of some promising nucleoside analogs against the COVID-19-Omicron variant. Computational Biology and Chemistry 104, pages 107768.
Crossref
Crossref
Chia-Kai Lin, Bor-Yann Chen, Jasmine U. Ting, Kristian Gil G. Rogio, Po-Wei Tsai & Yung-Chuan Liu. (2023) Deciphering Houttuynia cordata extract as electron shuttles with anti-COVID-19 activity and its performance in microbial fuel cells. Journal of the Taiwan Institute of Chemical Engineers 145, pages 104838.
Crossref
Crossref
Wafa A. Eltayb, Mohnad Abdalla & Amgad M. Rabie. (2023) Novel Investigational Anti-SARS-CoV-2 Agent Ensitrelvir “S-217622”: A Very Promising Potential Universal Broad-Spectrum Antiviral at the Therapeutic Frontline of Coronavirus Species. ACS Omega 8:6, pages 5234-5246.
Crossref
Crossref
Masanori Baba, Mika Okamoto, Masaaki Toyama, Norikazu Sakakibara, Masayuki Shimojima, Masayuki Saijo, Takuro Niwa & Yoshiki Yagi. (2023) Amodiaquine derivatives as inhibitors of severe fever with thrombocytopenia syndrome virus (SFTSV) replication. Antiviral Research 210, pages 105479.
Crossref
Crossref
Amgad M. Rabie & Mohnad Abdalla. (2022) Evaluation of a series of nucleoside analogs as effective anticoronaviral-2 drugs against the Omicron-B.1.1.529/BA.2 subvariant: A repurposing research study. Medicinal Chemistry Research 32:2, pages 326-341.
Crossref
Crossref
Amgad M. Rabie & Wafa A. Eltayb. (2023) Potent Dual Polymerase/Exonuclease Inhibitory Activities of Antioxidant Aminothiadiazoles Against the COVID-19 Omicron Virus: A Promising In Silico/In Vitro Repositioning Research Study. Molecular Biotechnology.
Crossref
Crossref
Amgad M. Rabie & Wafa A. Eltayb. (2023) Strong Dual Antipolymerase/Antiexonuclease Actions of Some Aminothiadiazole Antioxidants: A Promising In-Silico/In-Vitro Repurposing Research Study against the COVID-19 Omicron Virus (B.1.1.529.3 Lineage). Advances in Redox Research, pages 100064.
Crossref
Crossref
Amgad M. Rabie & Mohnad Abdalla. (2022)
Forodesine and Riboprine Exhibit Strong Anti-SARS-CoV-2 Repurposing Potential:
In Silico
and
In Vitro
Studies
. ACS Bio & Med Chem Au 2:6, pages 565-585.
Crossref
Crossref
Amgad M. Rabie & Mohnad Abdalla. (2022) A Series of Adenosine Analogs as the First Efficacious Anti‐SARS‐CoV‐2 Drugs against the B.1.1.529.4 Lineage: A Preclinical Repurposing Research Study. ChemistrySelect 7:46.
Crossref
Crossref
Maneesha Murali, Bhagyalakshmi Nair, V. R. Vishnu, T. P. Aneesh & Lekshmi R. Nath. (2022) 2,4-Dihydroxycinnamic acid as spike ACE2 inhibitor and apigenin as RdRp inhibitor in Nimbamritadi Panchatiktam Kashayam against COVID-19: an in silico and in vitro approach. Molecular Diversity.
Crossref
Crossref
Ahmed O. Mohammed, Mazin I. Abo-Idrees, Alaa A. Makki, Walaa Ibraheem & Abdulrahim A. Alzain. (2022) Drug repurposing against main protease and RNA-dependent RNA polymerase of SARS-CoV-2 using molecular docking, MM-GBSA calculations and molecular dynamics. Structural Chemistry 33:5, pages 1553-1567.
Crossref
Crossref
Kaifu Gao, Rui Wang, Jiahui Chen, Limei Cheng, Jaclyn Frishcosy, Yuta Huzumi, Yuchi Qiu, Tom Schluckbier, Xiaoqi Wei & Guo-Wei Wei. (2022) Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2. Chemical Reviews 122:13, pages 11287-11368.
Crossref
Crossref
Estefanía Calvo-Alvarez, Maria Dolci, Federica Perego, Lucia Signorini, Silvia Parapini, Sarah D’Alessandro, Luca Denti, Nicoletta Basilico, Donatella Taramelli, Pasquale Ferrante & Serena Delbue. (2022) Antiparasitic Drugs against SARS-CoV-2: A Comprehensive Literature Survey. Microorganisms 10:7, pages 1284.
Crossref
Crossref
Pawan K. Agrawal, Chandan Agrawal & Gerald Blunden. (2022) Artemisia Extracts and Artemisinin-Based Antimalarials for COVID-19 Management: Could These Be Effective Antivirals for COVID-19 Treatment?. Molecules 27:12, pages 3828.
Crossref
Crossref
Bechan Sharma. (2021) Meet the Editorial Board Member. Current Drug Therapy 16:2, pages 125-125.
Crossref
Crossref